The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

NCT00037219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidiasis

Interventions

DRUG: Anidulafungin, VER002

Sponsor

Pfizer

Collaborators

[object Object]